{
    "hands_on_practices": [
        {
            "introduction": "The most fundamental principle in calculating any disease rate is to correctly define the denominator: the population at risk. This group must only include individuals who are actually susceptible to the disease. This first exercise  provides a clear, practical scenario to demonstrate how including non-susceptible individuals—in this case, women who cannot develop cervical cancer due to prior hysterectomy—can systematically bias the comparison of incidence rates between two groups.",
            "id": "4643114",
            "problem": "A university health system is evaluating cervical cancer incidence between two clinics. The outcome is incident cervical cancer diagnosed during follow-up. Some enrolled women had a prior total hysterectomy before baseline, which removes the cervix and thus makes them not susceptible to cervical cancer during the study period. The distinction between the true population at risk and a naive denominator that ignores prior hysterectomy drives the difference in incidence rates.\n\nUse the following scientifically plausible dataset:\n\n- Clinic A enrolled $N_A = 2000$ women. At baseline, $H_A = 80$ were identified with prior total hysterectomy. Each enrolled woman was followed for $t_A = 2$ years. During follow-up, $E_A = 12$ incident cervical cancer cases occurred among women without prior hysterectomy.\n- Clinic B enrolled $N_B = 2500$ women. At baseline, $H_B = 250$ were identified with prior total hysterectomy. Each enrolled woman was followed for $t_B = 1.5$ years. During follow-up, $E_B = 9$ incident cervical cancer cases occurred among women without prior hysterectomy.\n\nStarting only from the fundamental definitions that (i) the population at risk comprises individuals susceptible to the event, (ii) the incidence rate equals the count of incident events divided by the total person-time at risk, and (iii) the Incidence Rate Ratio (IRR) is the ratio of two incidence rates, perform the following:\n\n1. Compute the correctly defined incidence rates for Clinic A and Clinic B using the population at risk that excludes women with prior hysterectomy, with rates expressed per person-year.\n2. Compute the naive incidence rates for Clinic A and Clinic B using denominators that include all enrolled women regardless of hysterectomy status, with rates expressed per person-year.\n3. Compute the correctly defined IRR (Clinic A relative to Clinic B) and the naive IRR.\n4. Compute the multiplicative bias factor defined as the ratio of the naive IRR to the correctly defined IRR. Express your final answer as a single simplified exact fraction. Do not include any units with your final answer.",
            "solution": "The solution proceeds by applying the provided definitions to the data in four sequential steps.\n\nThe fundamental formula for incidence rate ($IR$) is given by the number of new events ($E$) divided by the total person-time at risk ($PT$):\n$$IR = \\frac{E}{PT}$$\n\n**1. Compute the correctly defined incidence rates.**\n\nThe \"correct\" calculation uses the true population at risk, which excludes women who are not susceptible to cervical cancer due to prior total hysterectomy.\n\nFor Clinic A, the number of women at risk is:\n$$N_{A, \\text{risk}} = N_A - H_A = 2000 - 80 = 1920$$\nThe total person-time at risk for Clinic A is the number of women at risk multiplied by the follow-up duration:\n$$PT_{A, \\text{correct}} = N_{A, \\text{risk}} \\times t_A = 1920 \\times 2 = 3840 \\text{ person-years}$$\nThe correctly defined incidence rate for Clinic A is:\n$$IR_{A, \\text{correct}} = \\frac{E_A}{PT_{A, \\text{correct}}} = \\frac{12}{3840} \\text{ per person-year}$$\n\nFor Clinic B, the number of women at risk is:\n$$N_{B, \\text{risk}} = N_B - H_B = 2500 - 250 = 2250$$\nThe total person-time at risk for Clinic B is:\n$$PT_{B, \\text{correct}} = N_{B, \\text{risk}} \\times t_B = 2250 \\times 1.5 = 3375 \\text{ person-years}$$\nThe correctly defined incidence rate for Clinic B is:\n$$IR_{B, \\text{correct}} = \\frac{E_B}{PT_{B, \\text{correct}}} = \\frac{9}{3375} \\text{ per person-year}$$\n\n**2. Compute the naive incidence rates.**\n\nThe \"naive\" calculation incorrectly includes all enrolled women in the denominator, regardless of their susceptibility.\n\nFor Clinic A, the naive person-time is based on the total enrolled population:\n$$PT_{A, \\text{naive}} = N_A \\times t_A = 2000 \\times 2 = 4000 \\text{ person-years}$$\nThe naive incidence rate for Clinic A is:\n$$IR_{A, \\text{naive}} = \\frac{E_A}{PT_{A, \\text{naive}}} = \\frac{12}{4000} \\text{ per person-year}$$\n\nFor Clinic B, the naive person-time is:\n$$PT_{B, \\text{naive}} = N_B \\times t_B = 2500 \\times 1.5 = 3750 \\text{ person-years}$$\nThe naive incidence rate for Clinic B is:\n$$IR_{B, \\text{naive}} = \\frac{E_B}{PT_{B, \\text{naive}}} = \\frac{9}{3750} \\text{ per person-year}$$\n\n**3. Compute the correctly defined IRR and the naive IRR.**\n\nThe Incidence Rate Ratio ($IRR$) is the ratio of the incidence rate in Clinic A to that in Clinic B.\n\nThe correctly defined $IRR$ is:\n$$IRR_{\\text{correct}} = \\frac{IR_{A, \\text{correct}}}{IR_{B, \\text{correct}}} = \\frac{12/3840}{9/3375} = \\frac{12}{3840} \\times \\frac{3375}{9} = \\frac{12 \\times 3375}{3840 \\times 9}$$\n\nThe naive $IRR$ is:\n$$IRR_{\\text{naive}} = \\frac{IR_{A, \\text{naive}}}{IR_{B, \\text{naive}}} = \\frac{12/4000}{9/3750} = \\frac{12}{4000} \\times \\frac{3750}{9} = \\frac{12 \\times 3750}{4000 \\times 9}$$\n\n**4. Compute the multiplicative bias factor.**\n\nThe multiplicative bias factor is defined as the ratio of the naive $IRR$ to the correct $IRR$.\n$$ \\text{Bias Factor} = \\frac{IRR_{\\text{naive}}}{IRR_{\\text{correct}}} $$\nSubstituting the expressions from Step 3:\n$$ \\text{Bias Factor} = \\frac{\\left(\\frac{12 \\times 3750}{4000 \\times 9}\\right)}{\\left(\\frac{12 \\times 3375}{3840 \\times 9}\\right)} = \\frac{12 \\times 3750}{4000 \\times 9} \\times \\frac{3840 \\times 9}{12 \\times 3375} $$\nThe event counts ($E_A=12$ and $E_B=9$) cancel out:\n$$ \\text{Bias Factor} = \\frac{3750}{4000} \\times \\frac{3840}{3375} $$\nAlternatively, we can express this symbolically. The bias factor is:\n$$ \\text{Bias Factor} = \\frac{IRR_{\\text{naive}}}{IRR_{\\text{correct}}} = \\frac{\\frac{E_A/(N_A t_A)}{E_B/(N_B t_B)}}{\\frac{E_A/((N_A - H_A)t_A)}{E_B/((N_B - H_B)t_B)}} = \\frac{N_B(N_A-H_A)}{N_A(N_B-H_B)} $$\nSubstituting the given values into this symbolic expression:\n$$ \\text{Bias Factor} = \\frac{2500 \\times (2000 - 80)}{2000 \\times (2500 - 250)} = \\frac{2500 \\times 1920}{2000 \\times 2250} $$\nLet's simplify this fraction:\n$$ \\text{Bias Factor} = \\frac{25 \\times 100 \\times 1920}{20 \\times 100 \\times 2250} = \\frac{25 \\times 1920}{20 \\times 2250} = \\frac{5 \\times 1920}{4 \\times 2250} $$\nDividing $1920$ by $4$:\n$$ \\text{Bias Factor} = \\frac{5 \\times 480}{2250} = \\frac{2400}{2250} = \\frac{240}{225} $$\nBoth numerator and denominator are divisible by $5$:\n$$ \\frac{240 \\div 5}{225 \\div 5} = \\frac{48}{45} $$\nBoth are divisible by $3$:\n$$ \\frac{48 \\div 3}{45 \\div 3} = \\frac{16}{15} $$\nThe multiplicative bias factor is $\\frac{16}{15}$. This indicates that the naive calculation overestimates the true incidence rate ratio by a factor of approximately $1.067$. This is a direct consequence of the proportion of non-susceptible women being different between the two clinics ($H_A/N_A = 80/2000 = 4\\%$ in Clinic A vs. $H_B/N_B = 250/2500 = 10\\%$ in Clinic B).",
            "answer": "$$\\boxed{\\frac{16}{15}}$$"
        },
        {
            "introduction": "Building on the foundational concept of susceptibility, we now explore a more dynamic situation where an individual's risk status changes over time. This practice  tackles the critical issue of time-varying exposures and the resulting analytical pitfall known as 'immortal time bias'. By first performing a naive analysis and then a correctly time-updated one, you will directly observe how misclassifying person-time can lead to dangerously misleading conclusions about an exposure's effect.",
            "id": "4643050",
            "problem": "A closed cohort of $10$ individuals is enrolled at time $t=0$ months and followed for up to $24$ months for a first occurrence of a cardiovascular event. Some individuals initiate Drug $X$ during follow-up. Time is measured continuously in months from cohort entry. The exposure is Drug $X$ initiation; the outcome is the first event; censoring occurs at $24$ months or at the event, whichever comes first. The goal is to quantify the effect of Drug $X$ on the event using the concept of the population at risk and properly aligned risk sets.\n\nThe individual histories are given as follows (each line gives, in order, the time of Drug $X$ initiation if any, and the time of event or censoring):\n- ID $1$: initiates at $18$; event at $20$.\n- ID $2$: initiates at $16$; censored at $24$.\n- ID $3$: initiates at $12$; event at $22$.\n- ID $4$: initiates at $6$; censored at $24$.\n- ID $5$: initiates at $20$; event at $23$.\n- ID $6$: initiates at $8$; event at $9$.\n- ID $7$: initiates at $0$; event at $3$.\n- ID $8$: never initiates; event at $5$.\n- ID $9$: never initiates; event at $7$.\n- ID $10$: never initiates; censored at $24$.\n\nUsing only the core definitions of the population at risk, person-time, incidence rate (events per person-time), and incidence rate ratio (ratio of two incidence rates), do the following:\n\n$1.$ Conduct a naive ever-exposed analysis that classifies anyone who ever initiates Drug $X$ during follow-up as exposed for their entire observed time and those who never initiate as unexposed. Compute each group’s person-time, number of events, the corresponding incidence rates (per month), and the naive incidence rate ratio. Briefly explain why any apparent protective effect could arise from misaligned risk sets in terms of the population at risk.\n\n$2.$ Recompute the analysis using properly aligned, time-updated risk sets: for each individual, contribute person-time to the unexposed group from $t=0$ until Drug $X$ initiation (if any), then to the exposed group from initiation until event or censoring; individuals who never initiate contribute only to the unexposed group. Compute the exposed and unexposed person-time, events, the corresponding incidence rates (per month), and the correctly aligned incidence rate ratio.\n\nExpress the final answer as the correctly aligned incidence rate ratio (unitless). Round your final answer to three significant figures.",
            "solution": "The analysis is structured in two parts as requested: a naive analysis followed by a correctly aligned, time-updated analysis.\n\nLet $T_{init}$ be the time of Drug $X$ initiation and $T_{end}$ be the time of event or censoring. An individual's total follow-up time is $T_{end}$.\n\nThe individual data are:\n- ID $1$: $T_{init} = 18$, $T_{end} = 20$ (event)\n- ID $2$: $T_{init} = 16$, $T_{end} = 24$ (censored)\n- ID $3$: $T_{init} = 12$, $T_{end} = 22$ (event)\n- ID $4$: $T_{init} = 6$, $T_{end} = 24$ (censored)\n- ID $5$: $T_{init} = 20$, $T_{end} = 23$ (event)\n- ID $6$: $T_{init} = 8$, $T_{end} = 9$ (event)\n- ID $7$: $T_{init} = 0$, $T_{end} = 3$ (event)\n- ID $8$: No $T_{init}$, $T_{end} = 5$ (event)\n- ID $9$: No $T_{init}$, $T_{end} = 7$ (event)\n- ID $10$: No $T_{init}$, $T_{end} = 24$ (censored)\n\nThe incidence rate ($IR$) is defined as the number of new events ($D$) divided by the total person-time at risk ($PT$):\n$$IR = \\frac{D}{PT}$$\n\nThe incidence rate ratio ($IRR$) is the ratio of the incidence rate in the exposed group ($IR_E$) to the incidence rate in the unexposed group ($IR_U$):\n$$IRR = \\frac{IR_E}{IR_U}$$\n\n**1. Naive Ever-Exposed Analysis**\n\nIn this analysis, individuals are classified into fixed groups at time $t=0$.\n- **Exposed Group**: Individuals who ever initiate Drug $X$ (IDs $1, 2, 3, 4, 5, 6, 7$). There are $N_E = 7$ such individuals.\n- **Unexposed Group**: Individuals who never initiate Drug $X$ (IDs $8, 9, 10$). There are $N_U = 3$ such individuals.\n\nThe entire follow-up time for each individual is assigned to their respective group.\n\n*Calculation for the Exposed Group*:\n- Person-Time ($PT_E^{naive}$): The sum of the total follow-up times for individuals in the exposed group.\n$$PT_E^{naive} = 20 (\\text{ID } 1) + 24 (\\text{ID } 2) + 22 (\\text{ID } 3) + 24 (\\text{ID } 4) + 23 (\\text{ID } 5) + 9 (\\text{ID } 6) + 3 (\\text{ID } 7) = 125 \\text{ person-months}$$\n- Events ($D_E^{naive}$): The number of events in this group. Events occurred for IDs $1, 3, 5, 6, 7$.\n$$D_E^{naive} = 5 \\text{ events}$$\n- Incidence Rate ($IR_E^{naive}$):\n$$IR_E^{naive} = \\frac{D_E^{naive}}{PT_E^{naive}} = \\frac{5}{125} = 0.04 \\text{ events per person-month}$$\n\n*Calculation for the Unexposed Group*:\n- Person-Time ($PT_U^{naive}$): The sum of the total follow-up times for individuals in the unexposed group.\n$$PT_U^{naive} = 5 (\\text{ID } 8) + 7 (\\text{ID } 9) + 24 (\\text{ID } 10) = 36 \\text{ person-months}$$\n- Events ($D_U^{naive}$): The number of events in this group. Events occurred for IDs $8, 9$.\n$$D_U^{naive} = 2 \\text{ events}$$\n- Incidence Rate ($IR_U^{naive}$):\n$$IR_U^{naive} = \\frac{D_U^{naive}}{PT_U^{naive}} = \\frac{2}{36} = \\frac{1}{18} \\approx 0.0556 \\text{ events per person-month}$$\n\n*Naive Incidence Rate Ratio ($IRR^{naive}$)*:\n$$IRR^{naive} = \\frac{IR_E^{naive}}{IR_U^{naive}} = \\frac{5/125}{2/36} = \\frac{0.04}{1/18} = \\frac{1/25}{1/18} = \\frac{18}{25} = 0.72$$\n\n*Explanation of Flaw*:\nThe naive analysis yields an $IRR^{naive} < 1$, suggesting a protective effect of Drug $X$. This is a fallacious conclusion arising from a mis-specification of the population at risk, a phenomenon known as immortal time bias. In the \"ever-exposed\" group, the analysis incorrectly includes person-time accumulated *before* the initiation of Drug $X$ (e.g., for ID $1$, the $18$ months before starting the drug are counted as \"exposed\" time). By definition, an individual must survive without an event during this period to subsequently initiate the drug and be classified as exposed. This period of survival is \"immortal\" because if an event had occurred, the person would not have been in the ever-exposed group. Including this risk-free immortal time in the denominator ($PT_E^{naive}$) artificially inflates the person-time for the exposed group, which in turn artificially deflates their calculated incidence rate, creating the illusion of a protective effect. The risk sets are misaligned because individuals who are biologically unexposed are placed in the risk set for the exposed group.\n\n**2. Correctly Aligned, Time-Updated Analysis**\n\nIn this correct analysis, each individual's person-time is partitioned and contributed to the unexposed and exposed risk periods as they occur.\n- An individual contributes person-time to the **unexposed** risk set from cohort entry ($t=0$) until they initiate Drug $X$. If they never initiate, all their follow-up time is unexposed.\n- An individual contributes person-time to the **exposed** risk set from the time of Drug $X$ initiation until event or censoring.\n\n*Calculation for Unexposed Person-Time and Events*:\n- Person-Time ($PT_U^{aligned}$):\n  - From individuals who later initiate: $18 (\\text{ID } 1) + 16 (\\text{ID } 2) + 12 (\\text{ID } 3) + 6 (\\text{ID } 4) + 20 (\\text{ID } 5) + 8 (\\text{ID } 6) + 0 (\\text{ID } 7) = 80$ months.\n  - From individuals who never initiate: $5 (\\text{ID } 8) + 7 (\\text{ID } 9) + 24 (\\text{ID } 10) = 36$ months.\n  - Total: $$PT_U^{aligned} = 80 + 36 = 116 \\text{ person-months}$$\n- Events ($D_U^{aligned}$): Events that occur during the unexposed periods. These are the events in the never-initiator group.\n$$D_U^{aligned} = 2 \\text{ events (from ID } 8 \\text{ and ID } 9)$$\n- Incidence Rate ($IR_U^{aligned}$):\n$$IR_U^{aligned} = \\frac{D_U^{aligned}}{PT_U^{aligned}} = \\frac{2}{116} = \\frac{1}{58} \\text{ events per person-month}$$\n\n*Calculation for Exposed Person-Time and Events*:\n- Person-Time ($PT_E^{aligned}$): Calculated as $(T_{end} - T_{init})$ for each initiator.\n  - ID $1$: $20 - 18 = 2$\n  - ID $2$: $24 - 16 = 8$\n  - ID $3$: $22 - 12 = 10$\n  - ID $4$: $24 - 6 = 18$\n  - ID $5$: $23 - 20 = 3$\n  - ID $6$: $9 - 8 = 1$\n  - ID $7$: $3 - 0 = 3$\n  - Total: $$PT_E^{aligned} = 2 + 8 + 10 + 18 + 3 + 1 + 3 = 45 \\text{ person-months}$$\n- Events ($D_E^{aligned}$): Events that occur during the exposed periods (after initiation). These are the events in the initiator group.\n$$D_E^{aligned} = 5 \\text{ events (from IDs } 1, 3, 5, 6, 7)$$\n- Incidence Rate ($IR_E^{aligned}$):\n$$IR_E^{aligned} = \\frac{D_E^{aligned}}{PT_E^{aligned}} = \\frac{5}{45} = \\frac{1}{9} \\text{ events per person-month}$$\n\n*(Sanity check: Total PT = $PT_U^{aligned} + PT_E^{aligned} = 116+45 = 161$. Naive total PT = $125+36 = 161$. Total D = $D_U^{aligned} + D_E^{aligned} = 2+5 = 7$. Naive total D = $5+2 = 7$. Totals are conserved.)*\n\n*Correctly Aligned Incidence Rate Ratio ($IRR^{aligned}$)*:\n$$IRR^{aligned} = \\frac{IR_E^{aligned}}{IR_U^{aligned}} = \\frac{1/9}{1/58} = \\frac{58}{9} \\approx 6.444...$$\nRounding to three significant figures, the result is $6.44$. This reveals that Drug $X$ is strongly associated with an increased risk of the event, the opposite of the conclusion from the naive analysis.",
            "answer": "$$\\boxed{6.44}$$"
        },
        {
            "introduction": "Our final practice moves from conceptual understanding to detailed application, mirroring the work of an epidemiologist analyzing raw cohort data. This exercise  requires you to meticulously calculate the total person-time at risk by considering each individual's unique follow-up history, including staggered entry, censoring, and the occurrence of a competing event. Mastering this skill is essential for accurately estimating incidence rates in real-world longitudinal studies.",
            "id": "4643119",
            "problem": "A cohort study of cervical cancer follows women over a fixed administrative window of $5$ years starting at calendar time $t=0$. The scientific goal is to estimate the incidence rate of first primary cervical cancer by correctly defining the population at risk and excluding any person-time after total hysterectomy (which removes the cervix, eliminating the possibility of incident cervical cancer). Each woman $i$ has an entry time $a_i$ (possibly after $t=0$), an end-of-observation time $e_i$ (due to administrative end or loss to follow-up), a time of total hysterectomy $h_i$ if it occurs (otherwise none), and a first incident cervical cancer diagnosis time $c_i$ if it occurs (otherwise none). If a total hysterectomy occurs before enrollment, the woman never contributes at-risk time.\n\nDefine, for each woman $i$, an at-risk indicator function $I_i(t)$ that takes the value $1$ only when the woman is under observation, has not yet had a first cervical cancer diagnosis, and has an intact cervix (no hysterectomy yet), and takes the value $0$ otherwise. Use these indicators to compute the corrected incidence rate by appropriately aggregating person-time at risk and the number of incident cases.\n\nThe cohort comprises the following $8$ women, with times in years relative to $t=0$:\n- Woman $1$: $a_1=0.0$, $e_1=5.0$, $h_1=2.0$, $c_1=$ none.\n- Woman $2$: $a_2=1.0$, $e_2=5.0$, $h_2=4.0$, $c_2=3.5$.\n- Woman $3$: $a_3=0.5$, $e_3=5.0$, $h_3=0.8$, $c_3=$ none.\n- Woman $4$: $a_4=2.5$, $e_4=5.0$, $h_4=$ none, $c_4=$ none.\n- Woman $5$: $a_5=0.0$, $e_5=5.0$, $h_5=$ none, $c_5=4.7$.\n- Woman $6$: $a_6=0.0$, $e_6=5.0$, $h_6=3.0$, $c_6=2.0$.\n- Woman $7$: $a_7=1.2$, $e_7=3.0$, $h_7=1.8$, $c_7=$ none.\n- Woman $8$: $a_8=0.0$, $e_8=5.0$, $h_8=-1.0$ (hysterectomy before enrollment), $c_8=$ none.\n\nCompute the corrected incidence rate of first primary cervical cancer over the $5$-year window by:\n- Defining $I_i(t)$ for each woman $i$ so that person-time after hysterectomy is excluded and person-time after a first cervical cancer diagnosis is excluded.\n- Aggregating the total person-time at risk across all women.\n- Counting the number of incident cervical cancer diagnoses that occur while women are at risk.\n\nExpress the final incidence rate in cases per person-year. Round your answer to four significant figures. Do not use a percentage sign; express the rate as a decimal quantity in cases per person-year.",
            "solution": "The incidence rate, $\\lambda$, is defined as the number of new cases of a disease divided by the total person-time at risk in the population.\n$$ \\lambda = \\frac{\\text{Total number of new cases}}{\\text{Total person-time at risk}} $$\n\nFirst, we must define the period during which each woman is at risk. A woman $i$ is at risk starting from her entry into the study, $a_i$, and remains at risk until the first of the following events occurs:\n1. Diagnosis of first primary cervical cancer at time $c_i$.\n2. Total hysterectomy at time $h_i$.\n3. End of observation at time $e_i$.\n\nThe at-risk indicator function, $I_i(t)$, formalizes this. It is equal to $1$ if woman $i$ is at risk at time $t$, and $0$ otherwise. To handle events that do not occur, we can formally set their time to infinity. Let $C_i$ be the time of cancer and $H_i$ be the time of hysterectomy for woman $i$. If cancer is 'none', we set $C_i = \\infty$. If hysterectomy is 'none', we set $H_i = \\infty$.\n\nThe start of the at-risk period is the entry time, $t_{start,i} = a_i$.\nThe end of the at-risk period is the time of the first event that removes the woman from risk, $t_{end,i} = \\min(e_i, C_i, H_i)$.\n\nThe at-risk indicator function $I_i(t)$ is therefore:\n$$ I_i(t) = \\begin{cases} 1 & \\text{if } a_i \\le t  t_{end,i} \\\\ 0  \\text{otherwise} \\end{cases} $$\nThis definition intrinsically handles the case where an event occurs before or at entry ($t_{end,i} \\le a_i$), as the interval $[a_i, t_{end,i})$ is empty, and thus $I_i(t)=0$ for all $t$.\n\nThe person-time at risk for woman $i$, $PT_i$, is the total time she is at risk, which is the integral of the indicator function over the study period. This is equivalent to the length of her at-risk interval:\n$$ PT_i = \\int_{0}^{5} I_i(t) \\,dt = \\max(0, t_{end,i} - a_i) $$\n\nA woman $i$ is counted as an incident case if she is diagnosed with cervical cancer ($C_i  \\infty$) and this diagnosis occurs while she is at risk. This means the cancer diagnosis must happen at or after entry and strictly before any other censoring event. The condition for an incident case is:\n$$ a_i \\le C_i  \\min(e_i, H_i) $$\n\nWe now apply these definitions to each woman in the cohort.\n\n- **Woman 1**: $a_1=0.0$, $e_1=5.0$, $H_1=2.0$, $C_1=\\infty$.\n  - $t_{end,1} = \\min(5.0, \\infty, 2.0) = 2.0$.\n  - Person-time $PT_1 = \\max(0, 2.0 - 0.0) = 2.0$ years.\n  - Case? No, $C_1=\\infty$.\n\n- **Woman 2**: $a_2=1.0$, $e_2=5.0$, $H_2=4.0$, $C_2=3.5$.\n  - $t_{end,2} = \\min(5.0, 3.5, 4.0) = 3.5$.\n  - Person-time $PT_2 = \\max(0, 3.5 - 1.0) = 2.5$ years.\n  - Case? Yes. Check condition: $a_2 \\le C_2  \\min(e_2, H_2) \\implies 1.0 \\le 3.5  \\min(5.0, 4.0)=4.0$. The condition $1.0 \\le 3.5  4.0$ is true. She is a case.\n\n- **Woman 3**: $a_3=0.5$, $e_3=5.0$, $H_3=0.8$, $C_3=\\infty$.\n  - $t_{end,3} = \\min(5.0, \\infty, 0.8) = 0.8$.\n  - Person-time $PT_3 = \\max(0, 0.8 - 0.5) = 0.3$ years.\n  - Case? No, $C_3=\\infty$.\n\n- **Woman 4**: $a_4=2.5$, $e_4=5.0$, $H_4=\\infty$, $C_4=\\infty$.\n  - $t_{end,4} = \\min(5.0, \\infty, \\infty) = 5.0$.\n  - Person-time $PT_4 = \\max(0, 5.0 - 2.5) = 2.5$ years.\n  - Case? No, $C_4=\\infty$.\n\n- **Woman 5**: $a_5=0.0$, $e_5=5.0$, $H_5=\\infty$, $C_5=4.7$.\n  - $t_{end,5} = \\min(5.0, 4.7, \\infty) = 4.7$.\n  - Person-time $PT_5 = \\max(0, 4.7 - 0.0) = 4.7$ years.\n  - Case? Yes. Check condition: $a_5 \\le C_5  \\min(e_5, H_5) \\implies 0.0 \\le 4.7  \\min(5.0, \\infty)=5.0$. The condition $0.0 \\le 4.7  5.0$ is true. She is a case.\n\n- **Woman 6**: $a_6=0.0$, $e_6=5.0, H_6=3.0$, $C_6=2.0$.\n  - $t_{end,6} = \\min(5.0, 2.0, 3.0) = 2.0$.\n  - Person-time $PT_6 = \\max(0, 2.0 - 0.0) = 2.0$ years.\n  - Case? Yes. Check condition: $a_6 \\le C_6  \\min(e_6, H_6) \\implies 0.0 \\le 2.0  \\min(5.0, 3.0)=3.0$. The condition $0.0 \\le 2.0  3.0$ is true. She is a case.\n\n- **Woman 7**: $a_7=1.2$, $e_7=3.0$, $H_7=1.8$, $C_7=\\infty$.\n  - $t_{end,7} = \\min(3.0, \\infty, 1.8) = 1.8$.\n  - Person-time $PT_7 = \\max(0, 1.8 - 1.2) = 0.6$ years.\n  - Case? No, $C_7=\\infty$.\n\n- **Woman 8**: $a_8=0.0$, $e_8=5.0, H_8=-1.0$, $C_8=\\infty$.\n  - The hysterectomy occurred before study entry. She is never at risk.\n  - $t_{end,8} = \\min(5.0, \\infty, -1.0) = -1.0$.\n  - Person-time $PT_8 = \\max(0, -1.0 - 0.0) = \\max(0, -1.0) = 0$ years.\n  - Case? No, $C_8=\\infty$ and she was never at risk.\n\nNow, we aggregate the total person-time and total number of cases.\n\nTotal person-time at risk:\n$$ PT_{total} = \\sum_{i=1}^{8} PT_i = 2.0 + 2.5 + 0.3 + 2.5 + 4.7 + 2.0 + 0.6 + 0.0 = 14.6 \\text{ person-years} $$\n\nTotal number of incident cases:\n$$ C_{total} = (\\text{Woman 2}) + (\\text{Woman 5}) + (\\text{Woman 6}) = 1 + 1 + 1 = 3 \\text{ cases} $$\n\nFinally, we compute the incidence rate, $\\lambda$:\n$$ \\lambda = \\frac{C_{total}}{PT_{total}} = \\frac{3}{14.6} \\approx 0.20547945... \\text{ cases per person-year} $$\n\nThe problem requires the answer to be rounded to four significant figures.\nThe fifth significant figure is $7$, which is $\\ge 5$, so we round up the fourth significant figure.\n$ \\lambda \\approx 0.2055 $ cases per person-year.",
            "answer": "$$\\boxed{0.2055}$$"
        }
    ]
}